Search results
Results from the WOW.Com Content Network
Dihydrotestosterone (DHT, 5α-dihydrotestosterone, 5α-DHT, androstanolone or stanolone) is an endogenous androgen sex steroid and hormone primarily involved in the growth and repair of the prostate and the penis, as well as the production of sebum and body hair composition.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Androstanolone, or stanolone, also known as dihydrotestosterone (DHT) and sold under the brand name Andractim among others, is an androgen and anabolic steroid (AAS) medication and hormone which is used mainly in the treatment of low testosterone levels in men. [2]
"Providers are encouraged to consult with their local lab(s) to obtain hormone level reference ranges for both 'male' and 'female' norms, [which can vary,] and then apply the correct range when interpreting results based on the current hormonal sex, rather than the sex of registration." [3] Fenway Health: United States: 100–200 pg/mL <55 ng ...
Androgen replacement therapy formulations and dosages used in women Route Medication Major brand names Form Dosage Oral: Testosterone undecanoate: Andriol, Jatenzo: Capsule: 40–80 mg 1x/1–2 days Methyltestosterone: Metandren, Estratest: Tablet: 0.5–10 mg/day Fluoxymesterone: Halotestin: Tablet: 1–2.5 mg 1x/1–2 days Normethandrone a ...
To further test the role of activated androgen receptors on AHN, flutamide, an antiandrogen drug that competes with testosterone and dihydrotestosterone for androgen receptors, and dihydrotestosterone were administered to normal male rats. Dihydrotestosterone increased the number of BrdU cells, while flutamide inhibited these cells.
Hormone levels in gonadally intact adolescent and adult females with complete androgen insensitivity syndrome [1] [2]; Study Location n Age (years) LH (IU/L) FSH (IU/L) T (ng/dL)
Template:Medications and dosages used in hormone therapy for transgender men References ^ Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG (November 2017).